NYSE:DOCS - New York Stock Exchange, Inc. - US26622P1075 - Common Stock - Currency: USD
A fundamental analysis of (NYSE:DOCS): Should Quality-Oriented Investors Explore DOXIMITY INC-CLASS A (NYSE:DOCS)?
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Construction management software maker Procore (NYSE:PCOR) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Banking software provider Q2 (NYSE:QTWO) will be reporting results tomorrow afternoon. Here’s what to expect.
Shares of healthcare professional network Doximity (NYSE:DOCS) jumped 37.6% in the afternoon session after the company reported strong fourth-quarter results, and handily beat on the revenue, EBITDA, and EPS lines. Top line growth accelerated by 24% year on year, as the quarter benefited from strong platform engagement with over 610,000 providers using its clinical workflow tools and a 60% sequential growth in AI tool usage. Doximity also provided optimistic EBITDA guidance for the next quarter
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Roblox downgraded, Pinterest upgraded: Wall Street's top analyst calls
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Doximity exceeded expectations with strong revenue and net income growth, highlighting robust operational performance.
Healthcare professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 24.6% year on year to $168.6 million. On top of that, next quarter’s revenue guidance ($133 million at the midpoint) was surprisingly good and 4.7% above what analysts were expecting. Its non-GAAP profit of $0.45 per share was 34% above analysts’ consensus estimates.
Uncover the potential of DOXIMITY INC-CLASS A, a growth stock reasonably priced. NYSE:DOCS is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.